IDEAYA Biosciences (IDYA) EBIT Margin: 2020-2025
Historic EBIT Margin for IDEAYA Biosciences (IDYA) over the last 3 years, with Sep 2025 value amounting to 52.18%.
- IDEAYA Biosciences' EBIT Margin was N/A to 52.18% in Q3 2025 from the same period last year, while for Sep 2025 it was -73.86%, marking a year-over-year change of. This contributed to the annual value of -4,671.07% for FY2024, which is 409622.00% down from last year.
- IDEAYA Biosciences' EBIT Margin amounted to 52.18% in Q3 2025, which was up 102.53% from -2,059.11% recorded in Q4 2024.
- In the past 5 years, IDEAYA Biosciences' EBIT Margin registered a high of 52.18% during Q3 2025, and its lowest value of -2,059.11% during Q4 2024.
- In the last 3 years, IDEAYA Biosciences' EBIT Margin had a median value of -670.02% in 2023 and averaged -791.54%.
- As far as peak fluctuations go, IDEAYA Biosciences' EBIT Margin spiked by 13,271bps in 2022, and later slumped by 99,035bps in 2024.
- Quarterly analysis of 5 years shows IDEAYA Biosciences' EBIT Margin stood at -620.16% in 2021, then slumped by 3,730bps to -657.46% in 2022, then slumped by 41,131bps to -1,068.77% in 2023, then slumped by 99,035bps to -2,059.11% in 2024, then reached 52.18% in 2025.
- Its EBIT Margin stands at 52.18% for Q3 2025, versus -2,059.11% for Q4 2024 and -1,068.77% for Q4 2023.